Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Thursday, May 9, 2024.
CRISPR Therapeutics AG - Common Shares (NASDAQ:CRSP)
Strong Downtrend (-100) - CRSP is in a strong downtrend that is likely to continue. With short-term, intermediate, and long-term bearish momentum, CRSP continues to fall. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CRSP?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRSP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRSP
The long-term trend has been DOWN since Apr 16th, 2024 at 58.2900
The intermediate-term trend has been DOWN since Mar 11th, 2024 at 77.1014
The short-term trend has been DOWN since May 8th, 2024 at 55.2700
Smart Scan Analysis for CRSP
Based on our trend formula, CRSP is rated as a -100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 52.000 | 54.180 | 51.580 | 52.455 | -0.835 |
| Prev. Close | Volume | Bid | Ask | Time |
| 53.290 | 480078 | 2024-05-09 10:40:17 |
| Year High | 73.9 | Year High Date | 2018-05-24 |
| Year Low | 23.01 | Year Low Date | 2018-01-03 |
| 52wk High | 91.1 | 52wk High Date | 2024-02-22 |
| 52wk Low | 37.55 | 52wk Low Date | 2023-10-23 |
| Average Volume | 1,303,276 | Shares Outstanding | 80,276 |
| Market Cap | 2,616M | Assets | 222,957,100M |
| Liabilities | 346,768,000M | P/E Ratio | -8.27030000 |
| Volatility | 74.22 |